MY01: Funding, Investors & Team (Sep 2026)
MY01 provides a tool that can measure muscle pressure in real-time with precision, enabling users to respond promptly. Utilizing established sensitivity and specificity in diagnosing Acute Compartment Syndrome (ACS), MY01 was established in 2015 and is headquartered in Montréal, Quebec, Canada.
MY01 has raised $9.3M across 2 funding rounds on record, the most recent an undisclosed round announced in Aug 2024.
MY01 Company Profile and Key Stats
Latest funding round on record: Aug 2024.
MY01 Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
MY01 raised $9.3M in a Series A announced in Apr 2023.
1.3 years later, an undisclosed round was announced in Aug 2024 with no disclosed amount.
MY01 Founders and Leadership Team
Contact details for the MY01 team: 1 of 1 has an email address on file.
Start 14-day free trial →MY01 Funding Compared to Other Biotechnology Startups
Funded Startups Like MY01 in Biotechnology and Montréal
Companies Similar to MY01
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
MY01 Funding FAQs
What does MY01 do?
MY01 provides a tool that can measure muscle pressure in real-time with precision, enabling users to respond promptly. Utilizing established sensitivity and specificity in diagnosing Acute Compartment Syndrome (ACS), MY01 was established in 2015 and is headquartered in Montréal, Quebec, Canada.
How much funding has MY01 raised?
MY01 has raised $9.3M across 2 rounds on record.
When did MY01 last raise funding?
MY01's most recent funding round on record was announced in Aug 2024. The amount was not disclosed.
Who founded MY01?
FundedIQ lists Ed Harvey (Founder) at MY01.
Where is MY01 headquartered?
MY01 is based in Montréal, Quebec, Canada.
How many employees does MY01 have?
MY01 is in the 11-50 employee band.
About FundedIQ's MY01 Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MY01 is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.